Rubius Therapeutics Inc. (RUBY) Fell -8.1% or -1.28 To Price $14.53 On Friday


Rubius Therapeutics Inc. (RUBY) fell -8.1% or -1.28 to $14.53. It is approximately 111937 shares traded, which is 41.21% compare to the average total volume 271627. The market cap of RUBY is $1.16 billion. The year to date change is -20.75%. The 52 week price range is from $12.7 to $33.01. Price of RUBY have changed -2.83% during last week. It have changed -13.79% over last month, -0.44% over last 3 months, -31.17% over last 6 months and -34.80% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RUBY is 17.11. It is 17.76% above current price. The 200-day Moving Averages for RUBY is 17.94. It is 23.47% above current price. The 52-week High is 33.01. It is 127.19% from the current price. The 52-week Low is 12.7. It is -12.59% from current price.

There are some statistics of RUBY. It is has market cap $1.16 billion. The share outstanding is 79.93 million. The average volume is 271627. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RUBY is -39.68%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RUBY is -33.95%.


Tags:

Share this post